Y
Yoon Hong Choi
Researcher at Public Health England
Publications - 45
Citations - 2023
Yoon Hong Choi is an academic researcher from Public Health England. The author has contributed to research in topics: Vaccination & Pneumococcal conjugate vaccine. The author has an hindex of 23, co-authored 43 publications receiving 1825 citations. Previous affiliations of Yoon Hong Choi include Health Protection Agency & Rothamsted Research.
Papers
More filters
Journal ArticleDOI
Economic evaluation of human papillomavirus vaccination in the United Kingdom.
TL;DR: Routine vaccination of 12 year old schoolgirls combined with an initial catch-up campaign up to age 18 is likely to be cost effective in the UK and is robust to uncertainty in many parameters and processes.
Journal ArticleDOI
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
Cheryl Cohen,Joanne White,E. J. Savage,Judith R. Glynn,Yoon Hong Choi,Nick Andrews,David Brown,Mary Ramsay +7 more
TL;DR: As vaccinated children approach adolescence, immunity wanes, which may contribute to outbreaks of measles, mumps, andrubella.
Journal ArticleDOI
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
Marc Brisson,Marc Brisson,Élodie Bénard,Mélanie Drolet,Johannes A. Bogaards,Iacopo Baussano,Simopekka Vänskä,Mark Jit,Mark Jit,Marie-Claude Boily,Marie-Claude Boily,Megan Smith,Johannes Berkhof,Karen Canfell,Karen Canfell,Harrell W. Chesson,Emily A. Burger,Emily A. Burger,Yoon Hong Choi,Birgitte Freiesleben de Blasio,Birgitte Freiesleben de Blasio,Sake J. de Vlas,Giorgio Guzzetta,Jan A. C. Hontelez,Jan A. C. Hontelez,Johannes Horn,Martin Rudbeck Jepsen,Jane J. Kim,Fulvio Lazzarato,Fulvio Lazzarato,Suzette M. Matthijsse,Rafael T. Mikolajczyk,Andrew Pavelyev,M. Pillsbury,Leigh Anne Shafer,Stephen Tully,Hugo C. Turner,Cara Usher,Cathal Walsh +38 more
TL;DR: In this paper, a systematic review and meta-analysis of model predictions of the long-term population-level effectiveness of vaccination against human papillomavirus (HPV) infection in women and men, to examine the variability in predicted herd effects, incremental benefit of vaccinating boys, and potential for HPV-vaccine-type elimination.
Journal ArticleDOI
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
TL;DR: The quadrivalent vaccine may have an advantage over the bivalent vaccine in reducing healthcare costs and QALYs lost, however, considerable uncertainty remains about the differential benefit of the two vaccines.
Journal ArticleDOI
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom.
TL;DR: Dynamic models of human papillomavirus transmission were developed to describe the infection spread and development of cervical neoplasia, cervical cancer (squamous cell and adenocarcinoma) and anogenital warts and suggest that vaccinating 12-year-old girls at 80% coverage will result in a 38-82% reduction in cervical cancer incidence.